Köllensperger was an undergraduate student at the Technical University of Vienna where she used laser-based approaches for mass spectrometry.
[1] Köllensperger joined the University of Natural Resources and Life Sciences, BOKU, as an assistant professor.
[2] Köllensperger works alongside the Medical University of Vienna to improve the diagnosis and treatment of cancer patients.
Metal-based chemotherapies offer routes to precise and targeted cancer therapies, but do not always achieve positive outcomes and can result in side effects.
These anticancer drugs bind to the blood protein albumin, which is degraded by the tumour but less by health cells, and release in the malignant tissues beside cytotoxic chemotherapy.